1	Role	role	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	cellular	cellular	_	_	_	_	_	_	_
4	tumor	tumor	_	_	_	_	_	_	_
5	necrosis	necrosis	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	receptor-associated	receptor-associated	_	_	_	_	_	_	_
8	factors	factor	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	lymphocyte	lymphocyte	_	_	_	_	_	_	_
14	transformation	transformation	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	herpesvirus	herpesvirus	_	_	_	_	_	_	_
17	Saimiri	Saimiri	_	_	_	_	_	_	_
18	STP	STP	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	STP	STP	_	_	_	_	_	_	_
3	oncoproteins	oncoprotein	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	herpesvirus	herpesvirus	_	_	_	_	_	_	_
7	saimiri	saimiri	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	HVS	HVS	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	subgroup	subgroup	_	_	_	_	_	_	_
12	A	a	_	_	_	_	_	_	_
13	strain	strain	_	_	_	_	_	_	_
14	11	11	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	subgroup	subgroup	_	_	_	_	_	_	_
17	C	C	_	_	_	_	_	_	_
18	strain	strain	_	_	_	_	_	_	_
19	488	488	_	_	_	_	_	_	_
20	are	be	_	_	_	_	_	_	_
21	now	now	_	_	_	_	_	_	_
22	found	find	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	be	be	_	_	_	_	_	_	_
25	stably	stably	_	_	_	_	_	_	_
26	associated	associate	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	tumor	tumor	_	_	_	_	_	_	_
29	necrosis	necrosis	_	_	_	_	_	_	_
30	factor	factor	_	_	_	_	_	_	_
31	receptor-associated	receptor-associated	_	_	_	_	_	_	_
32	factor	factor	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	TRAF	TRAF	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	1	1	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	2	2	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	or	or	_	_	_	_	_	_	_
41	3	3	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	Mutational	mutational	_	_	_	_	_	_	_
2	analyses	analysis	_	_	_	_	_	_	_
3	identified	identify	_	_	_	_	_	_	_
4	residues	residue	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	PXQXT/S	pxqxt/s	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	STP-A11	stp-a11	_	_	_	_	_	_	_
9	as	as	_	_	_	_	_	_	_
10	critical	critical	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	TRAF	TRAF	_	_	_	_	_	_	_
13	association	association	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	somewhat	somewhat	_	_	_	_	_	_	_
6	divergent	divergent	_	_	_	_	_	_	_
7	region	region	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	STP-C488	stp-c488	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	critical	critical	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	TRAF	TRAF	_	_	_	_	_	_	_
14	association	association	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Mutational	mutational	_	_	_	_	_	_	_
2	analysis	analysis	_	_	_	_	_	_	_
3	also	also	_	_	_	_	_	_	_
4	revealed	reveal	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	STP-C488	stp-c488	_	_	_	_	_	_	_
7	induced	induce	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	correlated	correlate	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	its	its	_	_	_	_	_	_	_
15	ability	ability	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	associate	associate	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	TRAFs	TRAF	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	HVS	HVS	_	_	_	_	_	_	_
3	STP-C488	STP-C488	_	_	_	_	_	_	_
4	P10–>R	P10–>R	_	_	_	_	_	_	_
5	mutant	mutant	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	deficient	deficient	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	T-lymphocyte	T-lymphocyte	_	_	_	_	_	_	_
11	transformation	transformation	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	interleukin-2-independent	interleukin-2-independent	_	_	_	_	_	_	_
14	growth	growth	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	showed	show	_	_	_	_	_	_	_
17	wild-type	wild-type	_	_	_	_	_	_	_
18	phenotype	phenotype	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	marmoset	marmoset	_	_	_	_	_	_	_
21	T-lymphocyte	T-lymphocyte	_	_	_	_	_	_	_
22	transformation	transformation	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	vitro	vitro	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	vivo	vivo	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	STP-C488	stp-c488	_	_	_	_	_	_	_
3	P10–>R	p10–>r	_	_	_	_	_	_	_
4	mutant	mutant	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	also	also	_	_	_	_	_	_	_
7	defective	defective	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	Rat-1	rat-1	_	_	_	_	_	_	_
10	fibroblast	fibroblast	_	_	_	_	_	_	_
11	transformation	transformation	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	fibroblast	fibroblast	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	transformation	transformation	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	blocked	block	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	TRAF2	traf2	_	_	_	_	_	_	_
22	dominant-negative	dominant-negative	_	_	_	_	_	_	_
23	mutant	mutant	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	implicate	implicate	_	_	_	_	_	_	_
4	TRAFs	traf	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	STP-C488-mediated	stp-c488-mediated	_	_	_	_	_	_	_
7	transformation	transformation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	lymphocytes	lymphocyte	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	rodent	rodent	_	_	_	_	_	_	_
13	fibroblasts	fibroblast	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Other	other	_	_	_	_	_	_	_
2	factors	factor	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	implicated	implicate	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	immortalization	immortalization	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	common	common	_	_	_	_	_	_	_
9	marmoset	marmoset	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	may	may	_	_	_	_	_	_	_
14	also	also	_	_	_	_	_	_	_
15	be	be	_	_	_	_	_	_	_
16	critical	critical	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	transformation	transformation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	lymphocytes	lymphocyte	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	rodent	rodent	_	_	_	_	_	_	_
25	fibroblasts	fibroblast	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

